Menu
Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer
Cover image not available

Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer

National Institute for Health and Clinical Excellence

Publication Data

Descriptive Notes

Issue date: February 2011.
"This guidance was developed using the single technology appraisal process."

Topics

Catalogue Data

ISBD

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2011. Publication and catalogue information, links to buy online and reader comments.

obnb.uk is a Good Stuff website.